Carotenoids and Alzheimer's disease: an insight into therapeutic role of retinoids in animal models

Neurochem Int. 2011 Oct;59(5):535-41. doi: 10.1016/j.neuint.2011.04.004. Epub 2011 Jun 7.

Abstract

Carotenoids play a pivotal role in prevention of many degenerative diseases mediated by oxidative stress including neurodegenerative diseases like Alzheimer's Disease (AD). The involvement of retinoids in physiology, AD pathology and their therapeutic role in vitro and in vivo has been extensively studied. This review focuses on the role of carotenoids like retinoic acid (RA), all trans retinoic acid (ATRA), lycopene and β-carotene in prevention of AD symptoms primarily through inhibition of amyloid beta (Aβ) formation, deposition and fibril formation either by reducing the levels of p35 or inhibiting corresponding enzymes. The role of antioxidant micronutrients in prevention or delaying of AD symptoms has been included. This study emphasizes the dietary supplementation of carotenoids to combat AD and warrants further studies on animal models to unravel their mechanism of neuroprotection.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Alzheimer Disease / genetics
  • Alzheimer Disease / pathology
  • Animals
  • Antioxidants / adverse effects
  • Antioxidants / therapeutic use*
  • Carotenoids / adverse effects
  • Carotenoids / physiology
  • Carotenoids / therapeutic use*
  • Disease Models, Animal
  • Excitatory Amino Acid Transporter 2 / genetics
  • Humans
  • Lycopene
  • Micronutrients / physiology
  • Neuroprotective Agents / therapeutic use
  • Retinoids / therapeutic use*
  • Tretinoin / therapeutic use
  • Vitamin A / therapeutic use

Substances

  • Antioxidants
  • Excitatory Amino Acid Transporter 2
  • Micronutrients
  • Neuroprotective Agents
  • Retinoids
  • Vitamin A
  • Carotenoids
  • Tretinoin
  • Lycopene